Meeting
2014 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
Authors
Jeanne Tie
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Jeanne Tie , Isaac Kinde , Yuxuan Wang , Hui-li Wong , Iain Skinner , Rachel Wong , Malcolm Steel , Luis A. Diaz Jr., Nickolas Papadopoulos , Suzanne Kosmider , Desmond Yip , Craig Underhill , Andrew Mark Haydon , Michael Christie , Robert Strausberg , Kenneth W. Kinzler , Bert Vogelstein , Peter Gibbs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11015)
DOI
10.1200/jco.2014.32.15_suppl.11015
Abstract #
11015
Poster Bd #
4
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
First Author: Yoo Jin Joung
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2020 Gastrointestinal Cancers Symposium
Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).
First Author: Kristen Carroll